Get the Stockscreener App
85.31
0.86%
-0.74
After Hours:
85.31
Lemaitre Vascular Inc stock is traded at $85.31, with a volume of 107.72K.
It is down -0.86% in the last 24 hours and down -7.56% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$86.05
Open:
$86.61
24h Volume:
107.72K
Relative Volume:
0.65
Market Cap:
$1.93B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
46.62
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-2.49%
1M Performance:
-7.56%
6M Performance:
+3.01%
1Y Performance:
-5.83%
1-Day Range:
$85.00
$86.95
1-Week Range:
$85.00
$88.53
52-Week Range:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
85.31 | 1.95B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Using data models to predict LeMaitre Vascular Inc. stock movementIndex Update & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to LeMaitre Vascular Inc. stock2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Best data tools to analyze LeMaitre Vascular Inc. stock2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
When is the best time to exit LeMaitre Vascular Inc.Trade Signal Summary & Expert Approved Momentum Ideas - newser.com
Signal strength of LeMaitre Vascular Inc. stock in tech scanners2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
Published on: 2025-10-12 21:02:34 - newser.com
Published on: 2025-10-12 10:19:29 - newser.com
How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tighteningJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
LeMaitre Vascular (NASDAQ:LMAT) Earns Buy (B-) Rating from Weiss Ratings - MarketBeat
What technical models suggest about LeMaitre Vascular Inc.’s comeback2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Is a relief rally coming for LeMaitre Vascular Inc. holdersJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com
LeMaitre Vascular, Inc. Announces Third Quarter 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 - The Manila Times
Nov 6: LeMaitre Vascular to Announce Third-Quarter 2025 Results; Conference Call 5:00 PM EST - Stock Titan
What’s next for LeMaitre Vascular Inc. stock priceWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
What MACD signals say about LeMaitre Vascular Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Is now a turning point for LeMaitre Vascular Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
Is LeMaitre Vascular Inc. forming a bottoming base2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Detecting price anomalies in LeMaitre Vascular Inc. with AI2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Is LeMaitre Vascular Inc LHU a good long term investmentBollinger Bands Signals & Access Free Tools and Start Investing - earlytimes.in
Financial Review: LeMaitre Vascular (NASDAQ:LMAT) and Ingen Technologies (OTCMKTS:IGNT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $97.60 Consensus Price Target from Analysts - Defense World
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines - Yahoo Finance
LeMaitre Vascular Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
LeMaitre Vascular (LMAT): Unpacking Current Valuation After Steady Share Performance - Yahoo Finance
Smart tools for monitoring LeMaitre Vascular Inc.’s price actionWeekly Stock Report & Consistent Return Investment Signals - newser.com
State of Alaska Department of Revenue Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT - Defense World
10,744 Shares in LeMaitre Vascular, Inc. $LMAT Purchased by Public Employees Retirement System of Ohio - Defense World
Analyzing LeMaitre Vascular Inc. with risk reward ratio chartsJuly 2025 Decliners & Community Consensus Picks - newser.com
Multi asset correlation models including LeMaitre Vascular Inc.2025 Major Catalysts & Smart Allocation Stock Tips - newser.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
What MACD and RSI say about LeMaitre Vascular Inc.Quarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Copeland Capital Management LLC Sells 88,686 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Using R and stats models for LeMaitre Vascular Inc. forecasting2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
What drives LeMaitre Vascular Inc stock priceVWAP Trading Strategies & Build Diversified Portfolios With Ease - earlytimes.in
What analysts say about LeMaitre Vascular Inc stockMarket Sentiment Report & Superior Trading Ideas - earlytimes.in
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lemaitre Vascular Inc Stock (LMAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Roberts David B | President and Director |
Aug 11 '25 |
Option Exercise |
37.27 |
10,815 |
403,069 |
24,689 |
| Roberts David B | President and Director |
Aug 11 '25 |
Sale |
92.39 |
10,815 |
999,173 |
17,976 |
| Ross Bridget A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
2,500 |
93,225 |
5,416 |
| Ross Bridget A | Director |
Aug 08 '25 |
Sale |
94.00 |
2,500 |
235,000 |
2,916 |
| Roush John A | Director |
Aug 11 '25 |
Option Exercise |
37.29 |
6,561 |
244,660 |
9,477 |
| Roush John A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
939 |
35,015 |
3,855 |
| Roush John A | Director |
Aug 11 '25 |
Sale |
92.55 |
6,561 |
607,231 |
2,916 |
| Roush John A | Director |
Aug 08 '25 |
Sale |
93.49 |
939 |
87,784 |
2,916 |
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):